基于新版国际早产儿视网膜病变分类(ICROP 3)的5期早产儿视网膜病变手术后结构结局
本研究回顾性分析2004至2020年间接受玻璃体切除术的34例(54眼)5期早产儿视网膜病变(ROP)患者,按ICROP第三版将5期分为5A、5B、5C三个亚组。结果显示5A期完全视网膜复位16眼(88.9%),5B期13眼(39.4%),差异有统计学意义(P=0.0003);术后解剖失败与分期显著相关(5B vs 5A:比值比17.986,95%CI 3.712-148.502,P=0.0001)。术中玻璃体腔注射贝伐珠单抗与较低的术后玻璃体出血和青光眼发生率显著相关(P=0.041)。
要点
- ICROP 3的5期亚分类(5A/5B/5C)是预测玻璃体切除术后最终解剖成功的有用指标。
- 5A期完全视网膜复位16眼(88.9%),5B期13眼(39.4%),差异有统计学意义(P=0.0003)。
- 术中玻璃体腔注射贝伐珠单抗与较低的术后玻璃体出血和青光眼发生率显著相关(P=0.041)。
核心结论
- 基于ICROP 3对术前解剖特征进行分期是预测最终解剖成功的有用指标。
- 术中玻璃体腔注射贝伐珠单抗可能降低术后并发症风险。
研究设计与样本
- 回顾性分析2004至2020年间接受玻璃体切除术的34例患者共54眼5期ROP。
- 收集性别、出生孕周和体重、ICROP 3亚分类、围手术期玻璃体腔注射贝伐珠单抗和激光光凝、手术方式及并发症、最终视网膜复位和随访时间等数据。
主要发现
- 5A期完全视网膜复位16眼(88.9%),5B期13眼(39.4%),差异有统计学意义(P=0.0003,Wilcoxon秩和检验)。
- 3例5C期患者被认为无法手术。
- 术后解剖失败与分期显著相关(5B vs 5A:比值比17.986,95%CI 3.712-148.502,P=0.0001,多变量logistic回归分析)。
- 术中玻璃体腔注射贝伐珠单抗与较低的术后玻璃体出血和青光眼发生率显著相关(P=0.041,卡方检验)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: This study investigated the outcomes of vitrectomy for Stage 5 retinopathy of prematurity (ROP) based on the International Classification of Retinopathy of Prematurity third edition, in which Stage 5 ROP is divided into three subgroups. METHODS: Fifty-four eyes of 34 patients with Stage 5 ROP who underwent vitrectomy between 2004 and 2020 were retrospectively analyzed. Data including sex, gestational age and weight at birth, International Classification of Retinopathy of Prematurity 3 subcategories, perioperative use of intravitreal bevacizumab injection and laser photocoagulation, surgical procedure and complications, final retinal reattachment, and follow-up period were collected. RESULTS: Complete retinal reattachment was achieved in 16 eyes (88.9%) with Stage 5A and 13 eyes (39.4%) with Stage 5B ( P = 0.0003, Wilcoxon rank-sum test). Three patients with Stage 5C were considered inoperable. Postoperative anatomical failure was significantly associated with stage (Stage 5B vs. 5A; odds ratio, 17.986; 95% confidence interval, 3.712-148.502; P = 0.0001, multivariate logistic regression analysis). Intraoperative intravitreal bevacizumab was significantly associated with lower postoperative incidence of vitreous hemorrhage and glaucoma ( P = 0.041, chi-square test). CONCLUSION: Staging of preoperative anatomical features based on International Classification of Retinopathy of Prematurity 3 is a useful predictor for final anatomical success. Intraoperative intravitreal bevacizumab might reduce postoperative complication risks.
引用
- Mano F, Iwahashi C, Kuniyoshi K, et al. STRUCTURAL OUTCOME AFTER SURGERY FOR STAGE 5 RETINOPATHY OF PREMATURITY BASED ON THE NEW INTERNATIONAL CLASSIFICATION: ICROP 3. Retina. 2022. PMID: 35963009. doi:10.1097/IAE.0000000000003541
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。